Leading the way in childhood obesity.

Òmni Pediatrics

Semaglutide based weight loss for adolescents 12-17 years old with a BMI >95%

Please see Semaglutide pricing on our medications page.

GLP-1 LEARN MORE

Includes medical visit, prescription, all supplies, & free shipping.

Am I Eligible?

No hidden fees or insurance required.

Treating childhood obesity and managing pediatric health, requires caregiver support and healthy modeling. These are crucial to success. Factors like lifestyle, stress, genetics, and hormones contribute to weight gain in children. Along with GLP-1 medications, family-based interventions are key for success. Early intervention can prevent and reverse conditions like sleep apnea, high blood pressure, type 2 diabetes, heart disease, and cancer risk linked to overweight and obesity.

Semaglutide is the active ingredient in Ozempic®*/Wegovy®* approved for children 12 years and older with a BMI >95% to combat childhood obesity. These medications target insulin, appetite, and hunger mechanisms to facilitate weight loss. Establishing healthier habits is achievable as cravings and hormonal drivers are managed long-term in accordance with your child’s individual needs and healthcare provider’s recommendations.

If you’re here, you’ve made a powerful decision to help your child take control of their health. Early intervention for childhood obesity has a major impact on their health as adults. Join our community of successful members whose children are enjoying a healthier metabolic profile, an active lifestyle, and boosted self-esteem.

Am I Eligible?

Getting Started is Easy!

Check your eligibility by clicking the “Am I Eligible?” buttons on the page and filling out the form. We will contact you via email within 24 hours if you are eligible for our plans. If eligible, a link will be provided for purchase, lab orders if necessary, and a telehealth appointment. Schedule an appointment date that allows for bloodwork if you haven’t had blood drawn within the last year.

Complete HIPAA compliant medical forms (sent via email) detailing family and medical history, current medications, prior weight loss attempts, and upload lab results. Obtain blood work prior to your telehealth visit to avoid delays in prescriptions.

Meet with your medical provider. Discuss your intake form, lab results, and all options for medical weight loss, including dietary, exercise, and behavioral guidance.

Receive your scheduled medication in the mail directly from the compounding pharmacy.

This is just the beginning of a beautiful relationship! We continue to follow up with your progress, managing side effects, and making adjustments as needed.

Compounded medications are a safe and effective alternative to brand name medications.

Patients taking compounded medications get similar results as those taking commercial medications.

We’ve heard the concerns about improper compounding and want to put your mind at ease.

Per the Obesity Medicine Association statement “…compounding pharmacies are regulated by State Boards of Pharmacy and expected to comply with Current Good Manufacturing Practice (CGMP) requirements and may receive compounding accreditation… clinicians should verify safeguards such that the source anti-obesity medications and their formulations have undergone adequate clinical trial testing for efficacy and safety.”

At Omni Health NP, we vet our compounding pharmacies for good standing with their State Board of Pharmacy and the FDA.

The FDA-approved brand name drugs, such as Saxenda®, Victoza®, Wegovy®, and Ozempic® are exclusively available from the Novo Nordisk™ company. Mounjaro® and Zepbound™ are exclusively available from Eli Lilly and Company™.

Omni Health NP does not claim any affiliation with, or endorsement from, the above-mentioned products or entities. We do not offer non-compounded products unless insurance is used to obtain it commercially. Anyone seeking said products should discuss options with their licensed healthcare provider or pharmacist. Omni Health NP exclusively offers compounded medications, which are made in State Board of Pharmacy licensed sterile compounding pharmacies, or FDA-licensed 503(b) Outsourcing Facilities. While these facilities are strictly regulated, the compounded medications they make are not FDA-approved, as they are compounded based on an individual provider’s prescription for a specified patient. Strength, dose, route of administration, and other variables may make compounded medications different from FDA-approved drugs which makes directly comparing results & risk profile between FDA-approved drugs and compounded drugs difficult. Any compounded drugs prescribed are based on a licensed provider’s medical judgement based on a telehealth encounter and medical history.